Back to Results
First PageMeta Content
Phosphodiesterase inhibitor / Amrinone / CGMP-specific phosphodiesterase type 5 / Phosphodiesterase / Phospholamban / Rolipram / Heart failure / Myocyte / CAMP-dependent pathway / Biology / Phosphodiesterase-4 inhibitor / Pyridines


Phosphodiesterase 4D is required for ␤2 adrenoceptor subtype-specific signaling in cardiac myocytes Yang Xiang*†, Fabio Naro†‡§, Maria Zoudilova‡, S.-L. Catherine Jin‡, Marco Conti‡¶, and Brian Kobilka*¶
Add to Reading List

Document Date: 2009-12-04 19:10:48

Open Document

File Size: 313,79 KB

Share Result on Facebook

City

Seattle / Rockville / New Orleans / Berlin / Rome / L. A. / San Diego / /

Company

Hall D. D. / Gould / AMP / Table 1 / S. L. C. / Roche Biosciences / Singer / Green S. A. / Otsuka Pharmaceuticals / Schering / /

Country

Italy / United States / Scotland / /

/

Event

Business Partnership / /

Facility

cAMP PDE / M cAMP / cAMP Accumulation / When cAMP / PDE4 Enhances cAMP Accumulation / PDE4D complex / University of Washington School / /

IndustryTerm

culture media / real-time imaging / reaction product / contractile machinery / /

MedicalCondition

cardiac failure / pertussis / contraction / dilated cardiomyopathy / /

MusicGroup

the T / /

Organization

University of Washington School of Medicine / Fulbright Foundation / Stanford University School of Medicine / Division of Reproductive Biology / National Academy of Sciences / Department of Molecular / Department of Molecular and Cellular Physiology / Stanford / Department of Obstetrics and Gynecology / /

Person

L. Lan / Yang Xiang / Fabio Naro / Physiol / L. Catherine Jin / Scott / Brian Kobilka / Maria Zoudilova / Marco Conti / Joseph A. Beavo / /

Position

second messenger / General / Pitcher / Major / /

Product

amrinone / adenosine / /

ProvinceOrState

Washington / California / /

Technology

PKI / /

URL

www.pnas.org兾cgi兾doi兾10.1073兾pnas.0405263102 / /

SocialTag